Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: Data from the veterans aging cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 4, 2012, Pages 393-399

  Medapalli, Raj K ^a   Parikh, Chirag R ^b,c   Gordon, Kirsha ^c   Brown, Sheldon T ^a,d   Butt, Adeel A ^d,e,f   Gibert, Cynthia L ^d,g   Rimland, David ^d,h   Rodriguez Barradas, Maria C ^i,j   Chang, Chung Chou H ^e   Justice, Amy C ^d,k   He, John Cijiang ^a,d   Wyatt, Christina M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^g GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k YALE UNIVERSITY   (United States)

more..

Author keywords

chronic kidney disease; diabetes; HIV; non AIDS complications; risk factors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATAZANAVIR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDINAVIR; LOPINAVIR; TENOFOVIR;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; COMORBIDITY; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; VETERANS; YOUNG ADULT;

EID: 84864283310     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31825b70d9     Document Type: Article

References (23)

1. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165:1179-1184. (Pubitemid 40720744)
2. Butt AA, McGinnis K, Rodriguez-Barradas MC, et al. HIV infection and the risk of diabetes mellitus. AIDS. 2009;23:1227-1234.
3. De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care. 2008; 31:1224-1229.
4. Butt AA, Fultz SL, Kwoh CK, et al. Risk of diabetes in HIV infected veterans pre-and post-HAART and the role of HCV coinfection. Hepatology. 2004;40:115-119. (Pubitemid 38868929)
5. System USRD. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2010
6. Berliner AR, Fine DM, Lucas GM, et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol. 2008;28:478-486. (Pubitemid 351501614)
7. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145-1152. (Pubitemid 39121021)
8. Choi AI, Rodriguez RA, Bacchetti P, et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007;18:2968-2974. (Pubitemid 350058405)
9. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care. 2006;44:S25-S30. (Pubitemid 44284254)
10. Justice AC, Lasky E, McGinnis KA, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: a comparison of disease measurement strategies. Med Care. 2006;44:S52-S60. (Pubitemid 44284258)
11. Mocroft A, Kirk O, Reiss P, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010;24:1667-1678.
12. Braithwaite RS, Kozal MJ, Chang CC, et al. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 2007;21:1579-1589. (Pubitemid 47075479)
13. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116. (Pubitemid 27089212)
14. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
15. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351:1296-1305.
16. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
17. Freiberg MS, Chang CC, Skanderson M, et al. The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes. 2011;4:425-432.
18. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk Factors for ESRD in HIV-Infected Individuals: Traditional and HIV-Related Factors. Am J Kidney Dis. 2011;59:628-635.
19. Choi AI, Rodriguez RA, Bacchetti P, et al. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007;45:1633-1639. (Pubitemid 351411850)
20. Fischer MJ, Wyatt CM, Gordon K, et al. Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr. 2010;53:222-226.
21. Kim PS, Woods C, Georgoff P, et al. A1C underestimates glycemia in HIV infection. Diabetes Care. 2009;32:1591-1593.
22. Glesby MJ, Hoover DR, Shi Q, et al. Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study. Antivir Ther. 2010;15:571-577.
23. Worm SW, De Wit S, Weber R, et al. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation. 2009;119:805-811.